astrazeneca drug failure
shares drug closed failure iressa drug clinical
lung cancer drug prolong survival patients disease setback rejection pill exanta spinners cholesterol drug crestor mounting safety blockbuster drugs meant failing risks crestor nick turner brokers jefferies
astrazeneca hoped pitch iressa drug rival medicine tarceva iressa proved placebo extending involving patients tarceva osi pharmaceuticals genentech roche proved successful helping prolong lung cancer patients aztrazeneca appointed patterson charge drug patterson substantial clinical processes determined improve regulatory restore confidence shareholders tom mckillop
